期刊文献+

肝癌术后复发高危患者行TACE的意义 被引量:5

Significance of postoperative transcatheter arterial chemoembolization in high-risk patients with hepatocellular carcinoma
原文传递
导出
摘要 目的 探讨预防性经皮肝动脉化疗栓塞(transeatheter arterial chemoembolization,TACE)在防治高危患者术后复发中的意义.方法 回顾性分析54例有癌栓、子灶或合并多发结节、术后高AFP高危肝细胞癌患者,所有患者由同组手术医师手术,达到根治性切除手术要求.42例患者术后1~2月复查肝功能达到Child A级、肝炎病毒复制被控制在1000 copies/ml以下的高危患者行TACE术做为目标组.12例同样接受根治性手术治疗的高危患者因其他原因未接受TACE治疗做为对照组.通过2年的随访,比较2组的复发率,以了解术后TACE与高危患者复发的关系.结果 接受预防性TACE者术后1年肝内复发率(19.0%)明显低于未接受者(50%) 术后2年复发率同样明显低于未接受者(52.3%vs 83.3%).对不同时间段复发率进行分析,随着时间延长TACE组复发率逐渐增高接近对照组.结论 对于肝癌高危复发患者术后进行预防性TACE有助于减少术后近期肿瘤复发率. Objective To investigate the effect of postoperative prophylactic transcatheter arterial Chemoembolization(TACE) on preventing recurrence in 54 high-risk patients with hepatocellular carcinoma.Methods These 54 HCC cases were greded as high risk for recurrence and put on close follow up after radical resection.Risk factors included tumor thrombus,cancer satellite or multiple cancer nodules,postoperative high AFP level.Among them 42 cage (target group) received TACE,in which liver function was of Child A,and hepatitis virus replication was controlled in 1000 copies/ml.12 cases(centrol group) didn't receive TACE.The recurrent rate of HCC was compared between the cases with prophylactic TACE and those without through two years of follow-up. Result The recurrence rate of HCC was significantly lower in the cases with prophylactic TACE(19.O%) than those without(50%) within 1 year after the radical operation,and 2 years (52.3% vs 83.3%). Conclusion Postoperative TACE contributes to reducing the short-term HCC recurrence rate.
出处 《中华普通外科杂志》 CSCD 北大核心 2010年第6期490-492,共3页 Chinese Journal of General Surgery
基金 安徽省卫生厅青年课题基金资助项目(0913098)
关键词 肝细胞 肿瘤复发 局部 经皮肝动脉化疗栓塞 Carcinoma,hepatocellular Neoplasm recurrence,local TACE
  • 相关文献

参考文献8

  • 1Llovet JM,Bruix J.Systematic review of randomized trials for unresectable hepatocellular carcinoma:chemoembolization improves survival.Hepatology,2003,37:429442.
  • 2Hsu C,Cheng JCH,Cheng AL,et al.Recent advances in non-surgical treatment for advanced hepatocellular carcinoma.J Formos Med Assoc,2004,103:483495.
  • 3Lee WC,Jeng LB,Chen MF.Estimation of prognosis after hepatectomy for hepatocellular carcinoma.Br J Surg,2002,89:311-316.
  • 4Poon RTP,Fan ST,Ng IOL,et al.Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma.Cancer,2000,89:500-507.
  • 5刘鹏飞,刘荣华,徐荷,吴孟超.原发性肝癌术后预防性TACE的意义(附433例病例随访)[J].中华肝胆外科杂志,2005,11(2):81-82. 被引量:52
  • 6Lau WY,Lenng TWT,Ho SKW,et al.Adjuvant intra-arterial lipiodol iodine-131 for resectable hepatocellular carcinoma; a prospective randomized trial.Lancet,1999,353:797-801.
  • 7Lai ECS,Lo CM,Fan ST,et al.Postoperative adjuvant chemotherapy after curative resection of hepatocellular carcinoma:a randomized controlled trial.Arch Srug,1998,133:183-188.
  • 8孙建,简志祥,侯宝华,金浩生,区应亮,区金锐.术后预防TACE延缓微血管癌栓肝癌患者的抗复发作用[J].肝胆外科杂志,2008,16(1):20-23. 被引量:14

二级参考文献10

共引文献61

同被引文献37

  • 1张燕,左国庆,汤为学.奥沙利铂对人肝癌细胞株HepG2体外增殖的影响[J].中华肝脏病杂志,2004,12(6):374-375. 被引量:40
  • 2沈锋,吴孟超.肝癌切除术后的抗复发治疗[J].中华医学杂志,2005,85(41):2886-2888. 被引量:25
  • 3张坤,江艺,张绍庚,谢海英,谢志红.肝动脉化疗栓塞对原发性肝癌患者术后生存及肿瘤复发的影响[J].中国普通外科杂志,2007,16(3):206-208. 被引量:16
  • 4奚韬,闫振林,王葵,李俊,夏勇,沈锋,吴孟超.术后经导管动脉化疗栓塞对不同病理特征肝癌的抗复发作用[J].中华外科杂志,2007,45(9):587-590. 被引量:23
  • 5赵平,孔灵芝.肝癌.//全国肿瘤防治研究办公室.中国肿瘤死亡报告--全国第三次死因回顾抽样调查.1版.北京:人民卫生出版社,2010:37.
  • 6Portolani N, Coniglio A, Ghidoni S, et al. Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications. Ann Surg, 2006, 243: 229-235.
  • 7Shah SA, Greig PD, Gallinger S, et al. Factors associated with early recurrence after resection for hepatocellular carcinoma and outcomes. J Am Coil Surg, 2006, 202:275-283.
  • 8Shah SA,Greig PD,Gallinger S,Cattral MS,Dixon E,Kim RD,Taylor BR,Grant DR,Vollmer CM.Factors associated with early recurrence after resection for hepatocellular carcinoma and outcomes.J Am Coll Surg2006;202:275-283.
  • 9Mathurin P,Raynard B,Dharancy S,Kirzin S,Fal-lik D,Pruvot FR,Roumilhac D,Canva V,Paris JC,Chaput JC,Naveau S.Meta-analysis:evaluation of adjuvant therapy after curative liver resection for hepatocellular carcinoma.Aliment Pharmacol Ther2003;17:1247-1261.
  • 10Eguchi S,Matsumoto S,Hamasaki K,Takatsuki M,Hidaka M,Tajima Y,Sakamoto I,Kanematsu T.Re-evaluation of lipiodolized transarterial chemo-embolization therapy for intrahepatic recurrence of hepatocellular carcinoma after curative liver resection.J Hepatobiliary Pancreat Surg2008;15:627-633.

引证文献5

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部